IPHARMA is a well-established CRO that manages clinical trials in Russia and EAEU. Clinical branch of ChemRar group, and partner of Skolkovo Innovative center.
IPHARMA is the accredited common use center of "Skolkovo" Technopark and the member of ChemRar High-Tech Center group of companies, specialized in conducting clinical trials of innovative drugs in Russia and other EAEU countries.
IPHARMA provides a full cycle of the clinical drug development from the early phases to registration as well as the medical expertise and post-marketing programs based on the optimal strategy of commercial distribution. Currently we had completed more than 90 clinical trials in various therapeutic areas: oncology, virology, endocrinology, pulmonology, neurology, psychiatry, transplantation and others.
Our contract research organization is a reliable partner and an ideal platform for clinical development of new drugs.
1. Patient safety and public interests - ethical principles and social responsibility in decision-making
2. Partner and client confidence - honesty and commitment to fulfill obligations
3. Professionalism and sustainable development - openness to innovations and implementation of effective solutions
4. Objective and reliable data - compliance with the industry standards and quality control at each stage of a clinical trial
5. Progress of medical science and the health of future generations - ensuring the marketing authorization of safe and effective drugs
We organize clinical trials of investigational drugs developed by Russian and International pharmaceutical and biotech companies aimed at obtaining marketing authorization in the Russian Federation and EAEU countries. IPHARMA competent staff assures the quality and efficiency in conducting clinical trials in various therapeutic areas along with the qualified medical expertise, monitoring and data audit in accordance with international and local standards.
IPHARMA collaborates with the major pharmaceutical and biotech companies. Research facilities of ChemRar High-Tech Center increases the opportunities of IPHARMA clients in the field of chemical synthesis, development and production of finished dosage forms, conducting preclinical and bioanalytical trials, and the engagement of various financial instruments.
We provide free advice regarding the possibilities, time frames and budgets for the clinical trials of innovative drugs and generics. If necessary, we сan recommend to optimize the study design with the help of our Medical Advisors and Key Opinion Leaders (KOls) in the particular therapeutic area.
Our staff will do its best to exceed expectations of the most demanding customers.